1-13 of 13
Aleksandra Butrym
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

River-52: A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Cristina Papayannidis, Krzysztof Mądry, Piotr Centkowski, Witold Prejzner, Aleksandra Butrym, Dominik Chraniuk, Chadi Saba, Noemi Angelosanto, Ruth Curley, Hendrik Nogai, Renata Dudziak, Oleksandr Moybenko, Tomasz Rzymski, Milena Mazan, Agnieszka Sroka-Porada, Gary Wilkinson, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 6005.
https://doi.org/10.1182/blood-2024-206906
Published: 2024
Journal Articles

River-81: A Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess Safety, PK, PD, Clinical Efficacy of RVU120 in Combination with Venetoclax in Patients with AML Failing Prior Venetoclax Plus Hypomethylating Agent Therapy

Maria Benedetta Giannini, Adolfo De la Fuente Burguera, Adriano Venditti, Witold Prejzner, Sara García, Noemi Angelosanto, Hendrik Nogai, Renata Dudziak, Vakul Mohanty, Natalia Baran, Marta Obacz, Urszula Pakulska, Jerzy Woźnicki, Katarzyna Wiklik, Marta Micek, Tomasz Rzymski, Milena Mazan, Agnieszka Sroka-Porada, Gary Wilkinson, Aleksandra Butrym, Erika Borlenghi, Krzysztof Mądry, Jan Kulis, Diego Coelho, Daniel Grzywczak
Journal: Blood
Blood (2024) 144 (Supplement 1): 5999.
https://doi.org/10.1182/blood-2024-200055
Published: 2024
Journal Articles

The Premature Reduction of Venetoclax in an Initial Cycle of Ven-AZA Regimen for Unfit AML Patients Leads to Shortened Overall Survival - a Retrospective Study of Polish Adult Leukemia Group (PALG)

Lukasz Bolkun, Bozena Katarzyna Budziszewska, Bartosz Michal Pula, Joanna Drozd-Sokolowska, Krzysztof Mądry, Paweł Główka, Marta Sobas, Kinga Krawiec, Piotr Strzalka, Sylwia Kościołek-Zgódka, Jaroslaw Piszcz, Janusz Halka, Edyta Cichocka, Kamila Kruczkowska-Tarantowicz, Judyta Strzala, Agnieszka Mosler, Ewa Lech Marańda, Aleksandra Butrym, Sebastian Giebel, Agnieszka Wierzbowska
Journal: Blood
Blood (2024) 144 (Supplement 1): 2854.
https://doi.org/10.1182/blood-2024-208144
Published: 2024
Journal Articles

Results of a Phase 3 Study of Elderly Patients with Newly Diagnosed AML Treated with Sapacitabine and Decitabine Administered in Alternating Cycles

Hagop M. Kantarjian, MD, Kebede H. Begna, MD, Jessica K. Altman, MD, Stuart L. Goldberg, MD, Mikkael A. Sekeres, MD MS, Stephen A Strickland, Stephen E. Rubenstein, MD, Martha L. Arellano, MD, David F. Claxton, Maria R. Baer, MD, Marc Gautier, MD, Ellin Berman, MD, Karen Seiter, MD, Scott R Solomon, MD, Gary J. Schiller, MD, Selina Luger, MD FRCPC, Aleksandra Butrym, Gianluca Gaidano, MD PhD, Xavier Thomas, MD, Pau Montesinos, MD PhD, David A. Rizzieri, MD, Donald P. Quick, MD, Edward Agura, MD, Parameswaran Venugopal, MD, Janakiraman Subramanian, MD, Lori J. Maness, MD, Daniel-Eric Robert, MD, Yosr Hicheri, Tapan Kadia, MD, Farhad Ravandi, MBBS, Marc E. Buyse, ScD, Judy Chiao, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 891.
https://doi.org/10.1182/blood.V130.Suppl_1.891.891
Published: 2017
Journal Articles

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Clinical Trials & Observations
Hervé Dombret, John F. Seymour, Aleksandra Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James Cavenagh, Andre C. Schuh, Anna Candoni, Christian Récher, Irwindeep Sandhu, Teresa Bernal del Castillo, Haifa Kathrin Al-Ali, Giovanni Martinelli, Jose Falantes, Richard Noppeney, Richard M. Stone, Mark D. Minden, Heidi McIntyre, Steve Songer, Lela M. Lucy, C. L. Beach, Hartmut Döhner
Journal: Blood
Blood (2015) 126 (3): 291–299.
https://doi.org/10.1182/blood-2015-01-621664
Published: 2015
Includes: Supplemental data
Journal Articles

Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study

Hartmut Döhner, MD, John F Seymour, MBBS, FRACP, PhD, Aleksandra Butrym, MD, Agnieszka Wierzbowska, MD PhD, Dominik Selleslag, MD, Jun Ho Jang, MD, James D Cavenagh, MD, Rajat Kumar, FRCPC, Andre C Schuh, MD FRCPC, Anna Candoni, MD, Christian Récher, MDPhD, Irwindeep Sandhu, MD FRCPC, Teresa Bernal del Castillo, MD, Haifa Kathrin Al-Ali, MD, Giovanni Martinelli, MD, Jose Falantes, MD, Richard M. Stone, MD, Mark D. Minden, MD PhD, Heidi McIntyre, BS, Stephen Songer, PharmD, Lela M. Lucy, MS, CL Beach, PharmD, Hervé Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 621.
https://doi.org/10.1182/blood.V124.21.621.621
Published: 2014
Journal Articles

High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)

Aleksandra Butrym, MD PhD, Dagmara Baczynska, PhD, Andrzej Tukiendorf, Prof., Justyna Rybka, MD PhD, Tadeusz Dobosz, Prof., Wojciech Jurczak, Kazimierz Kuliczkowski, MD PhD Prof., Grzegorz Mazur, Prof.
Journal: Blood
Blood (2014) 124 (21): 5330.
https://doi.org/10.1182/blood.V124.21.5330.5330
Published: 2014
Journal Articles

Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (>30% Bone Marrow Blasts) with Morphologic Dysplastic Changes: A Subgroup Analysis of the AZA-AML-001 Trial

John F Seymour, MBBS, FRACP, PhD, Hartmut Döhner, MD, Aleksandra Butrym, MD, Agnieszka Wierzbowska, MD PhD, Dominik Selleslag, MD, Jun Ho Jang, MD, James D Cavenagh, MD, Rajat Kumar, MD, Andre C. Schuh, MD FRCPC, Anna Candoni, MD, Christian Récher, MDPhD, Irwindeep Sandhu, MD FRCPC, Teresa Bernal del Castillo, MD, Haifa Kathrin Al-Ali, MD, Giovanni Martinelli, MD, Jose Falantes, MD, Richard M Stone, Mark D. Minden, MD PhD, Heidi McIntyre, BS, Stephen Songer, PharmD, Lela M. Lucy, MS, CL Beach, PharmD, Hervé Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 10.
https://doi.org/10.1182/blood.V124.21.10.10
Published: 2014
Journal Articles

Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma – a Retrospective Analysis

Iwona Hus, Dariusz Jawniak, Magdalena Gorska-Kosicka, Aleksandra Butrym, Justyna Dzietczenia, Tomasz Wrobel, Grzegorz Mazur, MD, PhD, Ewa Lech-Maranda, Krzysztof Warzocha, MD, PhD, Anna Waszczuk-Gajda, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, MD PhD Prof, Lidia Poplawska, Jan Walewski, Anna Dmoszynska
Journal: Blood
Blood (2012) 120 (21): 4602.
https://doi.org/10.1182/blood.V120.21.4602.4602
Published: 2012
Journal Articles

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Agnieszka Pluta, MD, PhD, Tadeusz Robak, MD, PhD, Agata Wrzesien-Kus, MD, PhD, Bozena Katarzyna Budziszewska, MD, PhD, Kazimierz Sulek, MD, PhD, Ewa Wawrzyniak, PhD, Magdalena Czemerska, MD, Malgorzata Zwolinska, MD, Aleksandra Golos, MD, Aleksandra Holowiecka-Goral, MD, PhD, Slawomira Kyrcz-Krzemien, MD, PhD, Jaroslaw Piszcz, MD, PhD, Janusz Kloczko, MD, PhD, Monika Mordak, MD, Andrzej Lange, MD, PhD, Małgorzata Razny, MD, PhD, Krzysztof Madry, MD, PhD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Sebastian Grosicki, MD, PhD, Aleksandra Butrym, MD, Kazimierz Kuliczkowski, MD PhD, Krzysztof Warzocha, MD, PhD, Jerzy Holowiecki, MD, PhD, Agnieszka Wierzbowska, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3602.
https://doi.org/10.1182/blood.V120.21.3602.3602
Published: 2012
Journal Articles

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, MD, Jakub Debski, MD, Aleksandra Butrym, MD, Wojciech Legiec, MD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan Maciej Zaucha, MD, Marcin Rymko, MD, Tigran Torosian, MD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2011) 118 (21): 5125.
https://doi.org/10.1182/blood.V118.21.5125.5125
Published: 2011
Journal Articles

High Expression of Haematopoietic Cell Specyfic Lyn Substrate-1 (HS1) Predicts Survival of B-Cell Chronic Lymphocytic Leukemia Patients

Aleksandra Butrym, MD, PhD, Miroslaw Majewski, MD, Justyna Dzietczenia, MD, PhD, Tomasz Wrobel, prof., Kazimierz Kuliczkowski, MD PhD, prof., Grzegorz Mazur, prof.
Journal: Blood
Blood (2011) 118 (21): 2853.
https://doi.org/10.1182/blood.V118.21.2853.2853
Published: 2011
Journal Articles

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

Grzegorz Mazur, Emilia Jaskula, Ilona Kryczek, Dorota Dlubek, Tomasz Wrobel, MD, PhD, Aleksandra Butrym, Andrzej Lange, MD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2010) 116 (21): 3103.
https://doi.org/10.1182/blood.V116.21.3103.3103
Published: 2010